Literature DB >> 28269885

Bayesian Machine Learning Techniques for revealing complex interactions among genetic and clinical factors in association with extra-intestinal Manifestations in IBD patients.

E Menti1, C Lanera1, G Lorenzoni1, Daniela F Giachino2, Mario De Marchi2, Dario Gregori1, Paola Berchialla3.   

Abstract

The objective of the study is to assess the predictive performance of three different techniques as classifiers for extra-intestinal manifestations in 152 patients with Crohn's disease. Naïve Bayes, Bayesian Additive Regression Trees and Bayesian Networks implemented using a Greedy Thick Thinning algorithm for learning dependencies among variables and EM algorithm for learning conditional probabilities associated to each variable are taken into account. Three sets of variables were considered: (i) disease characteristics: presentation, behavior and location (ii) risk factors: age, gender, smoke and familiarity and (iii) genetic polymorphisms of the NOD2, CD14, TNFA, IL12B, and IL1RN genes, whose involvement in Crohn's disease is known or suspected. Extra-intestinal manifestations occurred in 75 patients. Bayesian Networks achieved accuracy of 82% when considering only clinical factors and 89% when considering also genetic information, outperforming the other techniques. CD14 has a small predicting capability. Adding TNFA, IL12B to the 3020insC NOD2 variant improved the accuracy.

Entities:  

Keywords:  Clinical Decision Support; Clinical research informatics; Data mining and statistical data analysis

Mesh:

Year:  2017        PMID: 28269885      PMCID: PMC5333221     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  10 in total

1.  Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients.

Authors:  Daniela Giachino; Marjan Maria van Duist; Silvia Regazzoni; Dario Gregori; Marco Bardessono; Paola Salacone; Nadia Scaglione; Raffaello Sostegni; Nicoletta Sapone; Francesca Bresso; Angela Sambataro; Ezio Gaia; Angelo Pera; Marco Astegiano; M De Marchi
Journal:  Eur J Hum Genet       Date:  2004-03       Impact factor: 4.246

2.  Bayesian networks in biomedicine and health-care.

Authors:  Peter J F Lucas; Linda C van der Gaag; Ameen Abu-Hanna
Journal:  Artif Intell Med       Date:  2004-03       Impact factor: 5.326

3.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

Review 4.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

5.  Modeling the role of genetic factors in characterizing extra-intestinal manifestations in Crohn's disease patients: does this improve outcome predictions?

Authors:  Daniela F Giachino; Silvia Regazzoni; Marco Bardessono; Mario De Marchi; Dario Gregori
Journal:  Curr Med Res Opin       Date:  2007-07       Impact factor: 2.580

6.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

7.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

8.  A systems biology approach: new insights into fetal growth restriction using Bayesian Networks.

Authors:  F Foltran; P Berchialla; S Bernasconi; E Grossi; D Gregori; M E Street
Journal:  J Biol Regul Homeost Agents       Date:  2011 Apr-Jun       Impact factor: 1.711

9.  The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants.

Authors:  David A van Heel; Bryan M Dechairo; Gary Dawson; Dermot P B McGovern; Kenichi Negoro; Alisoun H Carey; Lon R Cardon; Ian Mackay; Derek P Jewell; Nicholas J Lench
Journal:  Hum Mol Genet       Date:  2003-08-19       Impact factor: 6.150

10.  Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.

Authors:  J H Cho; D L Nicolae; L H Gold; C T Fields; M C LaBuda; P M Rohal; M R Pickles; L Qin; Y Fu; J S Mann; B S Kirschner; E W Jabs; J Weber; S B Hanauer; T M Bayless; S R Brant
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

  10 in total
  8 in total

Review 1.  A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases.

Authors:  I S Stafford; M Kellermann; E Mossotto; R M Beattie; B D MacArthur; S Ennis
Journal:  NPJ Digit Med       Date:  2020-03-09

Review 2.  Advances in Clinical Decision Support: Highlights of Practice and the Literature 2015-2016.

Authors:  R A Jenders
Journal:  Yearb Med Inform       Date:  2017-09-11

Review 3.  Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions.

Authors:  John Gubatan; Steven Levitte; Akshar Patel; Tatiana Balabanis; Mike T Wei; Sidhartha R Sinha
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

Review 4.  Artificial Intelligence Enhances Studies on Inflammatory Bowel Disease.

Authors:  Guihua Chen; Jun Shen
Journal:  Front Bioeng Biotechnol       Date:  2021-07-08

5.  A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.

Authors:  Imogen S Stafford; Mark M Gosink; Enrico Mossotto; Sarah Ennis; Manfred Hauben
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

6.  Artificial Intelligence for Inflammatory Bowel Diseases (IBD); Accurately Predicting Adverse Outcomes Using Machine Learning.

Authors:  Aria Zand; Zack Stokes; Arjun Sharma; Welmoed K van Deen; Daniel Hommes
Journal:  Dig Dis Sci       Date:  2022-04-27       Impact factor: 3.487

Review 7.  Artificial intelligence in small intestinal diseases: Application and prospects.

Authors:  Yu Yang; Yu-Xuan Li; Ren-Qi Yao; Xiao-Hui Du; Chao Ren
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

Review 8.  A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases.

Authors:  I S Stafford; M Kellermann; E Mossotto; R M Beattie; B D MacArthur; S Ennis
Journal:  NPJ Digit Med       Date:  2020-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.